Latest News for GNMSF

Genmab A/S (OTCMKTS:GNMSF - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $305.26 and traded as low as $275.30. Genmab A/S shares last traded at $275.30, with a volume of 8 shares traded. Genmab A/S Trading Down 5.1% The

Genmab A/S (GMAB) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Genmab A/S (GMAB) Q4 2025 Earnings Call Transcript

From a sector perspective, strength within Industrials and Information Technology offset relative weakness in Health Care. The October earnings report reinforced confidence in Comfort Systems' ability to convert a strong backlog and increasingly sophisticated project mix into sustained earnings growth. We did not make any adjustments to the position and continue to believe that the market opportunity remains robust.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for GNMSF.
Senate Trading
No Senate trades found for GNMSF.
U.S. House Trading
No House trades found for GNMSF.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
